NIHR Clinical Research Facility: Sheffield

Between 1 April 2026 and 31 March 2027, the following articles were published which relate to studies that have been supported by the NIHR Clinical Research Facility (CRF): Sheffield.

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study (STH21439: PHOSP-COVID)

Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study (STH23441: BRIDGE study)